BioSpace News Archive

Funds from operations and adjusted funds from operations (“AFFO”) for the three months ended June 30, 2019 totaled $0.40 and $0.42, respectively, per diluted common share.

Promises Behavioral Health (“Promises”), a growing national provider of comprehensive behavioral health, substance abuse treatment and related services, today announced that John P. Hart has joined the Company as Chief Financial Officer.

Favorable overall safety, tolerability, and pharmacokinetic profile of LHF-535 for Lassa fever demonstrated in first-in-human study

Ricardo Estape, M.D., a robotic gynecologic oncology surgeon specializing in robotic single incision surgeries from South Miami Gynecology Oncology Group, led the completion of the GLP studies.

Eurofins Genomics LLC announces that it has completed the acquisition of Blue Heron Biotech, a company specializing in advanced gene synthesis.

The Clorox® Total 360® System allows Baton Rouge’s leading women’s specialty hospital to protect patients from illness-causing pathogens and keep infection rates low

35-year clinical trials veteran will support Worldwide’s expanding global footprint and continued growth in booming life sciences market

As part of its ongoing work to promote excellence in oncology nursing and quality cancer care, the Oncology Nursing Society (ONS) launched the ONS Center for Innovation to guide the development of new resources, projects, programs, and applications for ONS’s existing products as well as the creation of new, innovative ones that meet the needs of oncology nurses—both now and in the future.

VenatoRx Pharmaceuticals today announced that it was named one of the “2019 Best Places to Work” in the Greater Philadelphia area by the Philadelphia Business Journal.

Advanced Protein Technology LLC, under the Nutra Collagen® brand, today officially launches it’s new “Collagen+" line.